Get startedLog in
    Picture of Swedish Orphan Biovitrum AB (publ) logo

    SOBI — Swedish Orphan Biovitrum AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Sobi to Acquire Arthrosi Therapeutics to Boost Gout Treatment Pipeline

    Picture of Swedish Orphan Biovitrum AB (publ) logoSwedish Orphan Biovitrum AB (publ)
    15/12/2025 14:12
    Dec 15 (Reuters) - Swedish Orphan Biovitrum AB SOBIV.ST:

SOBI TO ACQUIRE ARTHROSI THERAPEUTICS, STRENGTHENING PIPELINE FOR THE POTENTIAL TREATMENT OF GOUT

SOBI TO ACQUIRE ARTHROSI THERAPEUTICS, STRENGTHENING PIPELINE FOR THE POTENTIAL TREATMENT OF GOUT

SWEDISH ORPHAN BIOVITRUM - SOBI TO PAY $950 MILLION UPFRONT, UP TO $550 MILLION IN MILESTONES

SWEDISH ORPHAN BIOVITRUM - DEAL EXPECTED TO CLOSE IN H1 2026

Source text: ID:nPn7FSnHna

Further company coverage: SOBIV.ST

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Swedish Orphan Biovitrum AB (publ)

    See all news